Abstract
Key features
• Occurs worldwide
• Prevalence in developing countries >80%
• Mainly acquired in childhood, persisting for life
• Associated with chronic gastritis, peptic ulcer disease, gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma
• Defined by the World Health Organization (WHO) as class I carcinogen
• Diagnosed by variety of invasive and noninvasive methods
• Consensus guidelines exist regarding indications for treatment and treatment regimens
• Treatment requires multiday combination antibiotic therapy
• No vaccine is currently available
• Occurs worldwide
• Prevalence in developing countries >80%
• Mainly acquired in childhood, persisting for life
• Associated with chronic gastritis, peptic ulcer disease, gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma
• Defined by the World Health Organization (WHO) as class I carcinogen
• Diagnosed by variety of invasive and noninvasive methods
• Consensus guidelines exist regarding indications for treatment and treatment regimens
• Treatment requires multiday combination antibiotic therapy
• No vaccine is currently available
Original language | English |
---|---|
Title of host publication | Hunter's Tropical Medicine and Emerging Infectious Disease |
Subtitle of host publication | Ninth Edition |
Editors | Alan J. Magill, David R. Hill, Tom Solomon, Edward T. Ryan |
Chapter | 41 |
Pages | 437-441 |
Number of pages | 5 |
Edition | Ninth edition |
DOIs | |
Publication status | Published - 2013 |